.jpeg)
Is Trelagliptin covered by medical insurance?
Trelagliptin (Trelagliptin)The original drug has not yet been approved for marketing by the National Medical Products Administration in China, and therefore is not covered by medical insurance. The original drug produced by Japan's Takeda Pharmaceutical Factory has a specification of 100mg*20 tablets and a box price of around 2,500 RMB (the price may fluctuate due to exchange rates). Trelagliptin is a targeted drug for type 2 diabetes and is a dipeptidyl peptidase-4 (DPP-4) inhibitor. Trelagliptin increases insulin secretion by inhibiting the activity of DPP-4 enzyme and reduces glucagon secretion, thereby lowering blood sugar levels. This medication is often used in conjunction with a proper diet and exercise regimen to effectively manage type 2 diabetes.
[ 免责声明 ] 本页面内容来自公开渠道（如FDA官网、Drugs官网、原研药厂官网等），仅供持有医疗专业资质的人员用于医学药学研究参考，不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市，不适用于中国境内销售和使用。如需治疗，请咨询正规医疗机构。本站不提供药品销售或代购服务。
